Antipyrine And Benzocaine Otic
NDC Package 42192-708-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Antipyrine And Benzocaine Otic is a . Marketed by Acella Pharmaceuticals, Llc, this product is identified by NDC 42192-708.

Identification & Billing

NDC Package Code
42192-708-10
Package Description
10 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
42192070810
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
10 ML

Clinical Specifications

Proprietary Name
Antipyrine And Benzocaine Otic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Acella Pharmaceuticals, Llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
07-14-2009
End Marketing Date
07-31-2017
Listing Expiration
07-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42192-708-10 identifies a specific commercial package of 10 ml in 1 bottle, dropper of Antipyrine And Benzocaine Otic, labeled by Acella Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Acella Pharmaceuticals, Llc on July 14, 2009. The current certification is valid through July 31, 2017.

How is this Acella Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42192070810. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42192-708-10
11-Digit CMS (5-4-2)
42192-0708-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.